Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July
25. Mai 2017 07:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 25, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), today announced that top-line results for its reformulated SequestOx™ study are...
Elite Pharmaceuticals Announces New Management Appointments
24. Oktober 2014 07:15 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 24, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP),a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014
10. Februar 2014 15:26 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...